Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70313
Authors: Valeria Gutierrez de Piñeres, Claudia S. Tamayo‐Torres, Arantxa Ramirez‐Cisneros, Marianthi Kavelidou, Konstantinos Stefanakis, Christos S. Mantzoros
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Boehringer Ingelheim
OpenAlex ID: W4416677977